Alison T. Chin
Lawyers
Associate in our IP, Tech & Commercial Transactions practice.
Experience highlights
Recent Representations
- RayzeBio $358 million IPO
- AN2 Therapeutics $70 million follow-on offering
- Trinity Industries $400 million senior notes offering
- Editas Medicine $125 million follow-on offering
- Gamida Cell $23 million follow-on offering
- Nikola $100 million follow-on offerings
- Ormat Technologies $297 million follow-on offering
- Ardelyx $150 million at-the-market offering
- Eli Lilly $4 billion notes offering
- Intel $11 billion senior notes offering
- Roivant Sciences $230 million stock offering
- Pacific Biosciences $201.25 million follow-on offering
- Deciphera Pharmaceuticals $135.1 million common stock offering
- OPAL Fuels warrant exchange offer
- Terns Pharmaceuticals $86 million stock offering
- Illumina $1 billion notes offering
Education
J.D., Northwestern University Pritzker School of Law
- Production Editor, Northwestern Journal of Technology and Intellectual Property
B.S., Bioengineering and English Literature, California Institute of Technology
Professional history
- Davis Polk since 2021
Qualifications and admissions
- State of New York